Curiel DT - Search Results

1

Delivery route, MyD88 signaling and cross-priming events determine the anti-tumor efficacy of an adenovirus based melanoma vaccine.

Hangalapura BN, Oosterhoff D, Gupta T, de Groot J, Wijnands PG, van Beusechem VW, den Haan J, Tüting T, van den Eertwegh AJ, Curiel DT, Scheper RJ, de Gruijl TD. Hangalapura BN, et al. Among authors: curiel dt. Vaccine. 2011 Mar 9;29(12):2313-21. doi: 10.1016/j.vaccine.2011.01.022. Epub 2011 Jan 25. Vaccine. 2011. PMID: 21272606 Free PMC article.

2

Maturation of dendritic cells accompanies high-efficiency gene transfer by a CD40-targeted adenoviral vector.

Tillman BW, de Gruijl TD, Luykx-de Bakker SA, Scheper RJ, Pinedo HM, Curiel TJ, Gerritsen WR, Curiel DT. Tillman BW, et al. Among authors: curiel tj, curiel dt. J Immunol. 1999 Jun 1;162(11):6378-83. J Immunol. 1999. PMID: 10352250

3

Cancer vaccine strategies get bigger and better.

de Gruijl TD, Curiel DT. de Gruijl TD, et al. Among authors: curiel dt. Nat Med. 1999 Oct;5(10):1124-5. doi: 10.1038/13443. Nat Med. 1999. PMID: 10502808 No abstract available.

4

Targeting of adenoviral vectors through a bispecific single-chain antibody.

Haisma HJ, Grill J, Curiel DT, Hoogeland S, van Beusechem VW, Pinedo HM, Gerritsen WR. Haisma HJ, et al. Among authors: curiel dt. Cancer Gene Ther. 2000 Jun;7(6):901-4. doi: 10.1038/sj.cgt.7700198. Cancer Gene Ther. 2000. PMID: 10880021

5

Adenoviral vectors targeted to CD40 enhance the efficacy of dendritic cell-based vaccination against human papillomavirus 16-induced tumor cells in a murine model.

Tillman BW, Hayes TL, DeGruijl TD, Douglas JT, Curiel DT. Tillman BW, et al. Among authors: curiel dt. Cancer Res. 2000 Oct 1;60(19):5456-63. Cancer Res. 2000. PMID: 11034088

6

Combined targeting of adenoviruses to integrins and epidermal growth factor receptors increases gene transfer into primary glioma cells and spheroids.

Grill J, Van Beusechem VW, Van Der Valk P, Dirven CM, Leonhart A, Pherai DS, Haisma HJ, Pinedo HM, Curiel DT, Gerritsen WR. Grill J, et al. Among authors: curiel dt. Clin Cancer Res. 2001 Mar;7(3):641-50. Clin Cancer Res. 2001. PMID: 11297260

7

Selective gene delivery toward gastric and esophageal adenocarcinoma cells via EpCAM-targeted adenoviral vectors.

Heideman DA, Snijders PJ, Craanen ME, Bloemena E, Meijer CJ, Meuwissen SG, van Beusechem VW, Pinedo HM, Curiel DT, Haisma HJ, Gerritsen WR. Heideman DA, et al. Among authors: curiel dt. Cancer Gene Ther. 2001 May;8(5):342-51. doi: 10.1038/sj.cgt.7700313. Cancer Gene Ther. 2001. PMID: 11477454

8

Epidermal growth factor receptor targeting of replication competent adenovirus enhances cytotoxicity in bladder cancer.

van der Poel HG, Molenaar B, van Beusechem VW, Haisma HJ, Rodriguez R, Curiel DT, Gerritsen WR. van der Poel HG, et al. Among authors: curiel dt. J Urol. 2002 Jul;168(1):266-72. doi: 10.1097/00005392-200207000-00089. J Urol. 2002. PMID: 12050554

9

Gene therapy for meningioma: improved gene delivery with targeted adenoviruses.

Dirven CM, Grill J, Lamfers ML, Van der Valk P, Leonhart AM, Van Beusechem VW, Haisma HJ, Pinedo HM, Curiel DT, Vandertop WP, Gerritsen WR. Dirven CM, et al. Among authors: curiel dt. J Neurosurg. 2002 Aug;97(2):441-9. doi: 10.3171/jns.2002.97.2.0441. J Neurosurg. 2002. PMID: 12186474

10

Epidermal growth factor receptor targeting enhances adenoviral vector based suicide gene therapy of osteosarcoma.

Witlox MA, Van Beusechem VW, Grill J, Haisma HJ, Schaap G, Bras J, Van Diest P, De Gast A, Curiel DT, Pinedo HM, Gerritsen WR, Wuisman PI. Witlox MA, et al. Among authors: curiel dt. J Gene Med. 2002 Sep-Oct;4(5):510-6. doi: 10.1002/jgm.308. J Gene Med. 2002. PMID: 12221644

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

685 results

Search Page

Filters